Investigators have designed an antibody-based treatment that eliminated circulating tumor cells (CTCs) in mouse models of breast and pancreatic cancer. The research, which was led by scientists at Massachusetts General Hospital ...
Oct 20, 2022
0
50
Pancreatic cancer can be a devastating diagnosis due to its extremely aggressive nature and low survival rate. But there may be hope on the horizon thanks to scientists at RUSH who have discovered two new targets for decreasing ...
Feb 1, 2024
0
25
A new study from Nagoya University has unraveled a crucial link between how cancer cells cope with replication stress and the role of Taurine Upregulated Gene 1 (TUG1). By targeting TUG1 with a drug, the researchers were ...
Oct 12, 2023
0
49
(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published online May ...
May 25, 2012
0
0
Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, ...
Jan 24, 2019
0
2
A combination of the prodrug TH-302 and radiation may provide an effective treatment strategy for pancreatic cancer, according to preclinical results presented at the American Association for Cancer Research's Pancreatic ...
Jun 19, 2012
0
0
Cancer researchers have long hailed p53, a tumor-suppressor protein, for its ability to keep unruly cells from forming tumors. But for such a highly studied protein, p53 has hidden its tactics well.
Oct 9, 2017
0
90
The targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety of tumors harboring RET gene fusions, according to results from the international Phase I/II ARROW ...
May 29, 2020
0
0
Researchers at the Technical University of Munich (TUM) have developed a novel model system that can be used to precisely track the growth steps and three-dimensional arrangement of pancreatic cancer cells. It also provides ...
Oct 6, 2022
0
69
(Medical Xpress) -- A new class of anti-cancer drugs which control the growth and spread of cancers and do so with minimal side effects is being developed by researchers at the University of Sydney.
May 18, 2012
0
0
